Fig. 16
From: Roles of MXenes in biomedical applications: recent developments and prospects
a Anti-tumor effects of BG@NbSiR-scaffold-based PTT plus anti-PD-L1 immunotherapy. (i) Scheme diagram of BG@NbSiR-scaffold-based PTT plus anti-PD-L1 combination therapy to suppress tumor progression at the distant orthotopic site. Tumor images, weight, and volume diagrams of (ii) the primary and (iii) the distant tumors after mice were sacrificed. b Long-term protection efficacy against tumor recurrence by BG@NbSiR scaffold-based PTT plus anti-PD-L1 immunotherapy. (i) Schematic illustration of BG@NbSiR-scaffold-based PTT plus anti-PD-L1 combination therapy to inhibit tumor recurrence (n = 5). Tumor (ii) images, (iii) volume, and (iv) weight diagrams of the rechallenged tumors after mice were sacrificed. Reproduced with permission from Ref. [161], © John Wiley and Sons 2021.